Enter inventor name

CIPO Patents = 3

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 490(Granted Patents)

Location History:

75013 Paris, FR (1995)
Paris, FR (1983 - 2013)

Company Filing History:

Yeda Research and Develpment & Co. Ltd

patents

5 out of 5,089

Centre National De La Recherche Scientifique

patents

4. 3 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

patents

5. 2 out of 15

Institut Pasteur and Centre National De La Recherche Scientifique

patents

6. 2 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

7. 1 out of 1

Inst. Nat'l De La Sante Et Recherche

patent

8. 6 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2013

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8507196 - Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 (2013-08-13),

2. 8329396 - Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) (2012-12-11),

3. 7626013 - HIV-1 DNA fragments that hybridize to genomic HIV-1DNA (2009-12-01),

4. 7622266 - Identification of a synthetic ligand for retinoic acid receptor beta (2009-11-24),

5. 7585619 - Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity (2009-09-08),

6. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

7. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),

8. 6696420 - Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein (2004-02-24),

9. 6531585 - Steroid/thyroid hormone receptor-related gene which is inappropriately expressed in human hepatocellular carcinoma and which is a retinoic acid receptor (2003-03-11),

10. 6426216 - Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter (2002-07-30),

11. 6416996 - NUCLEOTIDE SEQUENCE COMPRISING THE GENOME OF HEPATITIS B VIRUS, NUCLEOTIDE SEQUENCE CODING THE SURFACE ANTIGEN OF THE HEPATITIS B VIRUS, VECTORS CONTAINING THE NUCLEOTIDE SEQUENCES, PROCESS FOR THE PREPARATION THEREOF, AND ANTIGEN OBTAINED THEREBY (2002-07-09),

12. 6410724 - Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same (2002-06-25),

13. 6225458 - Process for the production of DNA comprising the genome of the hepatitis B virus and vector including it (2001-05-01),

14. 6096879 - Nucleotide sequence comprising the genome of hepatitis B virus, (2000-08-01),

15. 6051426 - Vectors for transforming CHO cells (2000-04-18),

Title: Inventor Pierre Tiollais - Revolutionizing Technology in Paris

Introduction: Pierre Tiollais is a renowned inventor based in Paris, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pierre Tiollais holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Pierre Tiollais has worked with leading research institutions and technology companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Pierre Tiollais has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Pierre Tiollais continues to push the boundaries of technology and innovation, leaving a lasting legacy in the field of invention. His passion for creating solutions to complex challenges sets him apart as a visionary inventor in Paris, France.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com